Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Senior Director of Marketing & Communications:
Lauren Grella

Email: media@path.org

Recent Press Coverage

  1. PATH’s Nikolaj Gilbert and Dame Sally Davies write in The Telegraph about drug-resistant infections that are outpacing our ability to treat them—and how the global community must come together to address this growing global threat.
    Published: March 2025
  2. PATH is among the global partners receiving funding from the GHIT Fund’s $12.7 million investment to advance new diagnostics and drug development for malaria and neglected tropical diseases (NTDs).
    Published: January 2025
  3. Dr. Bilal Mateen, PATH’s Chief AI Officer, highlights GenAI’s potential in diagnostics, disease surveillance, and health communication while addressing challenges like data privacy and equity.
    Published: December 2024
  4. Dr. Cathy Ndiaye, Director of HPV Vaccine Programs at PATH, shares her personal connection to the fight against cervical cancer and her efforts to address disparities in prevention and care.
    Published: November 2024

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

948 Item s
948 Item s
    Date
    From
    To
  1. This important milestone will provide countries with an additional option for HPV vaccination at an affordable price and will contribute to sustainable supply of HPV vaccine—allowing more girls to be reached with HPV vaccines.
    Published: October 2021
    Announcement
  2. Experts endorse successful completion of initial use period
    Published: October 2021
    Press Release
  3. Published: October 2021
    Press Release
  4. Vaccine shown to be cost-effective and trusted by caregivers and health care workers
    Published: October 2021
    Statement
  5. PATH commits to helping vaccinate 70 percent of the world by September 2022, to saving lives now, and to better preparing the world for the next health threat.
    Published: September 2021
    Press Release